FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

AI power players pour cash into competitive primaries as 2026 midterms heat up

Shutdown clock ticks as Schumer, Democrats dig in on DHS funding demands

Watch: Acting ICE Director Thwarts Eric Swalwell’s ‘Gotcha Question’ During Hearing

Watch: Bench-Clearing Brawl Throws NBA Game Into Chaos, Leads to 4 Ejections

DHS says illegal immigrant injured head after hitting concrete wall while fleeing ICE, denies beating claims

Fact Check: Did Bad Bunny Feature Viral 5-Year-Old Liam Ramos in Super Bowl Halftime Show?

DHS urges Newsom to honor ICE detainers after federal agent assaulted while arresting illegal alien at jail

Supreme Court Justice Alito says ‘things are so different’ since Scalia’s death

Clinton Judge Responds to California’s Attempts to Unmask ICE Agents

China panics after Takaichi declares intention to remilitarize Japan

Only one local detective on Nancy Guthrie case has over two years of experience on homicide squad: sources

Trump thanked Florida police for Epstein probe in 2000s, flagged ‘evil’ Ghislaine Maxwell: FBI doc

Progressive backed by Sanders, AOC pulls off upset ballot box shocker in Democratic congressional primary

US Skier Lindsey Vonn Reveals Extent of Her Injuries After Brutal Crash Ends Her Olympics — And Possibly Career

Who Would Have Guessed? Transit Agency in Cold-Weather State Buys EV Buses, Can’t Use Them in Freezing Cold

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”